Quest Diagnostics Reports Second Quarter 2017 Financial Results, Raises 2017 Financial Outlook

Go back to Quest Diagnostics Reports Second Quarter 2017 Financial Results, Raises 2017 Financial Outlook

Quest Diagnostics (DGX) Tops Q2 EPS by 13c; Raise Outlook

July 25, 2017 6:48 AM EDT

Quest Diagnostics (NYSE: DGX) reported Q2 EPS of $1.55, $0.13 better than the analyst estimate of $1.42. Revenue for the quarter came in at $1.94 billion versus the consensus estimate of $1.94 billion.

"We turned in another strong quarter and are delivering on all five elements of our... More